| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | | Total Revenue | 2,914,457 | 6,019,847 | | Cost of Revenue | 993,014 | 2,248,742 | | | Gross Profit | 1,921,443 | 3,771,105 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 1,222,549 | 459,866 | | Non Recurring | 82,755 | 79,523 | | Others | 57,841 | 54,820 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 558,298 | 3,176,896 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 15,054 | 61,251 | | Earnings Before Interest And Taxes | 573,352 | 3,238,147 | | Interest Expense | 562,955 | 3,234,548 | | Income Before Tax | 10,397 | 3,599 | | Income Tax Expense | 41,877 | 66,587 | | Minority Interest | (976) | (4,871) | | | | Net Income From Continuing Ops | (48,610) | (69,542) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (48,610) | (69,542) | | Preferred Stock And Other Adjustments | (20,627) |
-
| | | Net Income Applicable To Common Shares | ($69,237) | ($69,542) |
|
0.78% Nasdaq 
Income Statement
